Please verify that you are a Healthcare Professional. Register for complete access to all the content!
Test Description ENTest Description ENTest Description ENTest Description ENTest Description ENTest Description ENTest Description EN
FDA releases alert regarding invasive disease risk in preterm infants receiving...
As per the FDA, the administration of probiotics formulated to contain live bacteria or yeast to preterm infants in hospital settings poses a significant risk o...
WHO recommends multivitamins for pregnancy in updated essential medicines list
WHO has updated its Essential Medicines List to include a range of essential multivitamins and micronutrient supplements for pregnant women, aiming to enhance m...
FDA greenlights first biosimilar for multiple sclerosis treatment
For the management of multiple sclerosis, the FDA has granted approval to the first biosimilar (Natalizumab-sztn).
WHO recommends Rituximab off-label use in multiple sclerosis
WHO has endorsed groundbreaking public health measures concerning novel Essential Medicines for the treatment of multiple sclerosis.
FDA greenlights first-ever oral medication for postpartum depression
Zuranolone has received FDA approval for addressing postpartum depression in adults.
FDA approves revolutionary cellular therapy, Lantidra, for type 1 diabetes treat...
FDA approval of Lantidra offers hope to adults suffering from type 1 diabetes who struggle with severe hypoglycemia, despite intensive management efforts.
RSV vaccine wins FDA approval for people aged 60 years and above
In older adults, FDA has authorized the first Respiratory Syncytial Virus vaccine to prevent lower respiratory tract illness.
FDA thumbs up to a recent breakthrough in treatment of knee osteoarthritis
A new implantable shock absorber can help individuals with symptomatic knee osteoarthritis for easing pain and relish their lifestyle and interests.
Unique FDA-approved therapy for constipation. Read to know!
Novel vibrating therapy may be used to ease constipation without the use of any drugs.
Lecanemab-irmb gets accelerated FDA approval for Alzheimer's Disease
FDA has given accelerated approval to Lecanemab-irmb for Alzheimer’s disease management.
Albuterol/Budesonide Combination Rescue Inhaler gets FDA approval for asthma
For the as-needed management or prophylaxis of bronchoconstriction and to lessen asthma episodes risk in asthma-affected people (18 years of age and older), the...
First gene therapy for Hemophilia B receives FDA approval
For management of Hemophilia B in adults, the FDA has authorized a single-dose gene therapy Etranacogene dezaparvovec.
This website uses cookies to help us give you the best experience when you visit.
By using this website you consent to our use of cookies. For more information please review our cookie policy.